The association of Neutrophil-to-Lymphocyte ratio with metabolic syndrome in U.S. Adults: Findings from the 1999-2018 National Health and Nutrition Examination survey [0.03%]
美国成人胰岛素抵抗与代谢综合征的关联：基于1999-2018年全国健康和营养检查调查的结果
Zahra Sarrafan-Chaharsoughi,Ninet Sinaii,Andrew P Demidowich et al.
Zahra Sarrafan-Chaharsoughi et al.
Background: Identifying and treating metabolic syndrome (MetS) early is of great importance, as MetS portends numerous negative health outcomes. Identifying an inexpensive, readily available inflammatory biomarker that ac...
Glucagon-like peptide1 receptor agonist treatment of cystic fibrosis-related diabetes complicated by obesity: A cases series and literature review [0.03%]
关于肥胖囊性纤维化相关糖尿病患者使用GLP-1受体激动剂治疗的病例系列研究及文献综述
Ammar Ahmed,Anvitha Ankireddypalli,Tasma Harindhanavudhi et al.
Ammar Ahmed et al.
Cystic fibrosis-related diabetes (CFRD) is the most common non-pulmonary comorbidity in people with cystic fibrosis (CF). Current guidelines recommend insulin therapy as the treatment of choice for people with CFRD. In the past, obesity and...
Corrigendum to "Safety and efficacy of semaglutide in post kidney transplants patients with type 2 diabetes or post-transplant diabetes" [J. Clin. Translat. Endoc. 36C (2024) 100343] [0.03%]
关于“司美格鲁肽在肾移植后2型糖尿病或移植后糖尿病患者中的安全性和有效性”的勘误（卷36C，100343）
Moeber Mohammed Mahzari,Omar Buraykan Alluhayyan,Mahdi Hamad Almutairi et al.
Moeber Mohammed Mahzari et al.
[This corrects the article DOI: 10.1016/j.jcte.2024.100343.]. © 2024 The Author(s).
The right drug for the right patient at the right time with the right test in differentiated thyroid cancer (DTC) [0.03%]
适当的时间、适当的检测、适当的患者和适当的药物在分化型甲状腺癌中的应用
Dario de Biase,Andrea Repaci,Maria Concetta Nigro et al.
Dario de Biase et al.
Thanks to the identification of crucial molecular pathways, the therapeutic landscape for advanced differentiated thyroid tumors (DTCs) has significantly improved during the last ten years. The therapeutic scenario has been greatly impacted...
The effects of gender-affirming hormone therapy on myocardial, hepatic, pancreatic lipid content, body fat distribution and other cardiometabolic risk factors: A magnetic resonance-based study in transgender individuals [0.03%]
性别肯定激素治疗对心肌、肝脏、胰腺脂质含量、体脂分布及其他心血管代谢危险因素的影响：一项关于跨性别人群的磁共振成像研究
Dorota Sluková,Carola Deischinger,Ivica Just et al.
Dorota Sluková et al.
Purpose: We aimed to assess the changes in body fat distribution, intraorgan lipid accumulation, and cardiometabolic risk factors after 6 months of gender-affirming hormone therapy (GAHT) in transgender men (TM) and trans...
Simple prediction model for vitamin D deficiency in women with osteoporosis or risk factors for osteoporosis in Thailand [0.03%]
泰国绝经后妇女骨质疏松症或骨质疏松危险因素维生素D缺乏预测模型
Tidaporn Mullikapipat,Natee Dumrongwongsuwinai,Orawin Vallibhakara et al.
Tidaporn Mullikapipat et al.
Introduction: In Thailand, the assessment of vitamin D status by measuring 25-hydroxyvitamin D[25(OH)D] levels in individuals at risk for osteoporosis is constrained by limited facilities and high costs. This study aimed ...
Stephen L Atkin,Alexandra E Butler,Tannaz Jamialahmadi et al.
Stephen L Atkin et al.
Eating habits and carotenoid skin content among children based on their attendance at the school meals: A cross-sectional pilot study [0.03%]
基于学校供餐参与度的学龄前儿童饮食习惯及皮肤类胡萝卜素含量横断面研究
Giovanna Caparello,Fabrizio Ceraudo,Francesca Meringolo et al.
Giovanna Caparello et al.
Objective: The promotion of a healthy diet, such as the Mediterranean Diet (MD), among childhood is of a particular importance, since eating behaviors learned early in life have been shown to be maintained into adolescenc...
The bio-artificial pancreas to treat type 1 diabetes: Perspectives from healthcare professionals in the Netherlands [0.03%]
荷兰医疗专业人员对用于治疗1型糖尿病的生物人工胰腺的看法
Dide de Jongh,Eline Bunnik,Behiye Ozcan et al.
Dide de Jongh et al.
Aims: Healthcare professionals are relevant stakeholders because of their gatekeeper role in the clinic. This study aims to explore their perspectives on the potential future clinical implementation of the bio-artificial ...
Association between incretin-based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: A large population-based matched cohort study [0.03%]
基于肠泌素的药物与2型糖尿病患者的胆管癌风险关联：一项大规模人群匹配队列研究
Arunkumar Krishnan,Carolin V Schneider,Hendrik-Tobias Arkenau et al.
Arunkumar Krishnan et al.
Aim: To examine the association between the use of incretin-based drugs [glucagon-like peptide-1 receptor agonists (GLP-1RAs), dipeptidyl peptidase-4 inhibitors (DPP-4Is)] and the risk of cholangiocarcinoma (CCA) in the U...